MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

To be or not to bupropion: a drug-induced parkinsonism?

A. Silva, J. Pinto, M. Gago, M. Rodrigues (Braga, Portugal)

Meeting: 2022 International Congress

Abstract Number: 506

Keywords: Drug-induced parkinsonism(DIP)

Category: Drug-Induced Movement Disorders

Objective: To draw attention to drug-induced parkinsonism.

Background: Although the main causes of parkinsonism are degenerative, there are some reversible causes, including drug-induced parkinsonism.

Method: Description of a clinical case.

Results: A 70-year-old male patient with multiple vascular risk factors, presented with apathy, hypomimia, hypophonia and slowness of movements for several months following the death of his mother. He had hyposmia and REM sleep behaviour disorder for several years. There was no history of neuroleptic medication or family history of neurological or Parkinson Disease. He was started on bupropion 300mg. Over the following weeks, the family noticed progressive worsening of his gait, with short strides, shuffling gait, loss of arms movements, camptocormia and repeated falls. His wife denied other autonomic dysfunctions and cognitive or behavioural changes. On examination, he had dysarthria and dysphonia and severe bilateral bradykinesia and rigidity (H&Y stage 3). Brain MRI revealed small lacunar infarcts. He was treated with increasing doses of levodopa, with partial response. The following months he could barely walk unassisted and developed dysphagia. Safinamide and opicapone were also tried, with minimal response. He was hospitalized twice due to aspiration pneumonia, with marked worsening of his general condition. After the second hospitalization (12 months later), buproprion was switched to sertraline and the parkinsonian syndrome markedly improved, with full recovery of his autonomy. Six months later, his mental status was normal. There was no hypomimia, scanning speech or hypophonia. He had a fine postural tremor, which was absent at rest, and mild bradykinesia on his left arm without resistance to passive movement. He was able to walk unassisted, with marked improvement in walking velocity, stride amplitude and arms swing.

Conclusion: Despite the widely known benefit of bupropion (a norepinephrine-dopamine reuptake inhibitor) in the treatment of Parkinson’s disease depressive symptoms, REM sleep behaviour and restless legs syndrome, rare cases of tremor, parkinsonism and dystonia have been described in association with this drug.  123I-Ioflupane/SPECT would help distinguish a pure bupropion-induced parkinsonism from bupropion worsening of a potentially degenerative parkinsonian syndrome. Vascular parkinsonism is unlikely, given symptoms improvement.

To cite this abstract in AMA style:

A. Silva, J. Pinto, M. Gago, M. Rodrigues. To be or not to bupropion: a drug-induced parkinsonism? [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/to-be-or-not-to-bupropion-a-drug-induced-parkinsonism/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/to-be-or-not-to-bupropion-a-drug-induced-parkinsonism/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley